Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-11-13-Speech-2-264"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech²
dcterms:Date	"2001-11-13"^^xsd:date²
dcterms:Is Part Of	lp_eu:Question Time (Commission)²
dcterms:Language	"el"^^xsd:language²
lpv:document identification number	"en.20011113.11.2-264"²
lpv:hasSubsequent	lp_eu:2001-11-13-Speech-2-265²
lpv:speaker	lp:Minerva Melpomeni Malliori²
lpv:spokenAs	substitute; Temporary committee on human genetics and other new technologies in modern medicine (2000-12-13--2001-11-29)³ member; Delegation to the EU-Russia Parliamentary Cooperation Committee (1999-10-06--2002-01-14)³ unknown; Panellinio Socialistiko Kinima (1999-07-20--2004-07-19)³ member; PES (1999-07-20--2004-07-19)³ substitute; Committee on Citizens' Freedoms and Rights, Justice and Home Affairs (2000-02-23--2002-01-14)³ member; Committee on the Environment, Public Health and Consumer Policy (1999-07-21--2002-01-14)³
lpv:translated text	"As you perhaps know, doping substances are traded on the free market so quickly that often, when one substance is detected and banned, a new one has already appeared. The reasons for this are purely bureaucratic, for the simple reason that there are not enough laboratories. Does the Commission intend to help so that substances can be recognised and banned immediately, thereby reducing the time available for new substances to reach the free market?"@en¹

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph